The Africa Study Bible, a study Bible developed with contributions from African scholars and church leaders, has been ...

PARK CITY, Utah and HERZLIYA, Israel, July 6, 2021 /PRNewswire/ -- BlueWind Medical, Ltd. a leading innovator of neuromodulation medical devices for the treatment for overactive bladder (OAB), ...

Wegovy pill, the first oral GLP-1 for weight loss, is FDA-approved for reducing cardiovascular risks in adults. Phase III OASIS 4 trial showed 16.6% mean weight loss with oral semaglutide, ...

PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and developer of the Revi ® System, a patient-centric solution for urgency urinary ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (Nasdaq:EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, ...

Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) Trial is sponsored by the ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

Changes are needed at Grand Island's Island Oasis water park. Through consulting firm Waters Edge of Kansas, community input sessions were held in June and August, and an online survey had 489 ...

Seattle Children's is partnering on the launch of a study called the 'Oto-Acoustic Signals in SIDS' (OASIS) study that will investigate a possible association between Sudden Infant Death Syndrome ...

Charles Schwab was deemed to have one of the strongest custodian platforms, and TradePMR ranked for the best trading capabilities among 10 peers, according to a new in-depth study performed by The ...